Array-comparative genomic hybridization of central chondrosarcoma: Identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations

Cancer

Volumn 107, Issue 2, 2006, Pages 380-388

  Rozeman, Leida B ^a   Szuhai, Karoly ^a   Schrage, Yvonne M ^a   Rosenberg, Carla ^a,b   Tanke, Hans J ^a   Taminiau, Antonie H M ^a   Cleton Jansen, Anne Marie ^a   Bovée, Judith V M G ^a   Hogendoorn, Paneras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Array comparative genomic hybridization; Bone neoplasm; Chondrosarcoma; Enchondroma

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 4; PROTEIN S6;

ANALYSIS OF VARIANCE; ARTICLE; CDK4 GENE; CHONDROSARCOMA; CHROMOSOME 12; CHROMOSOME 6; CHROMOSOME LOSS; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ENCHONDROMA; GENE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; PPFIBP1 GENE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RPS6 GENE; STUDENT T TEST; TUMOR GROWTH;

BONE NEOPLASMS; CARRIER PROTEINS; CHONDROSARCOMA; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 6; CYCLIN-DEPENDENT KINASE 4; ENCHONDROMATOSIS; FEMALE; GENES, NEOPLASM; GENOMIC INSTABILITY; HUMANS; MALE; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RIBOSOMAL PROTEIN S6;

EID: 33745808004     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22001     Document Type: Article

References (32)

1. Bertoni F, Bacchini P, Hogendoorn PCW. Chondrosarcoma. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organisation classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002;247-251.
2. Mulder JD, Schutte HE, Kroon HM, Taconis WK. Radiologic atlas of bone tumors, 2nd ed. Amsterdam: Elsevier, 1993.
3. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40:818-831.
4. Bovee JVMG, Cleton-Jansen AM, Wuyts W, et al. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet. 1999;65:689-698.
5. Bovee JVMG, Cleton-Jansen AM, Kuipers-Dijkshoorn N, et al. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma. Genes Chromosomes Cancer. 1999;26:237-246.
6. Bovee JVMG, Sciot R, Dal Cin P, et al. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol. 2001;10:228-236.
7. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. Cancer Genet Cytogenet. 2003;143:1-31.
8. Mandahl N, Gustafson P, Mertens F, et al. Cytogenetic aberrations and their prognostic impact in chondrosarcoma. Genes Chromosomes Cancer. 2002;33:188-200.
9. Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge JA. Cytogenetic findings in benign cartilaginous neoplasms. Cancer Genet Cytogenet. 2003;141:164-168.
10. Rozeman LB, Hogendoorn PCW, Bovee JVMG. Diagnosis and prognosis of chondrosarcoma of bone. Expert Rev Mol Diagn. 2002;2:461-472.
11. Asp J, Sangiorgi L, Inerot SE, et al. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. Int J Cancer. 2000;85:782-786.
12. van Beerendonk HM, Rozeman LB, Taminiau AHM, et al. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression. J Pathol. 2004;202:359-366.
13. Lucas DR, Bridge JA. Chondromas: enchondroma, periosteal chondroma, and enchondromatosis. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002:237-240.
14. Bovee JVMG, Graadt van Roggen JF, Cleton-Jansen AM, Taminiau AHM, Van der Woude HJ, Hogendoorn PCW. Malignant progression in multiple enchondromatosis (Ollier's disease): an autopsy-based molecular genetic study. Hum Pathol. 2000;31:1299-1303.
15. Ozisik YY, Meloni AM, Spanier SS, Bush CH, Kingsley KL, Sandberg AA. Deletion Ip in a low-grade chondrosarcoma in a patient with Ollier disease. Cancer Genet Cytogenet. 1998;105:128-133.
16. Hopyan S, Gokgoz N, Poon R, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet. 2002;30:306-310.
17. Rozeman LB, Sangiorgi L, Briaire-de Bruijn IH, et al. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. Hum Mutat. 2004;24:466-473.
18. Odink AE, van Asperen CJ, Vandenbroucke JP, Cleton-Jansen AM, Hogendoorn PC. An association between cartilaginous tumours and breast cancer in the national pathology registration in the Netherlands points towards a possible genetic trait. J Pathol. 2001;193:190-192.
19. Knijnenburg J, Szuhai K, Giltay J, et al. Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet. 2005;132A:36-40.
20. Greshock J, Naylor TL, Margolin A, et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res. 2004;14:179-187.
21. Jong K, Marchiori E, Meijer G, van der Vaart A, Ylstra B. Chromosomal breakpoint detection in human cancer. Bioinformatics. 2004;20:3636-3637.
22. Rozeman LB, Hameetman L, van Wezel T, et al. cDNA expression profiling of central chondrosarcomas: Ollier disease resembles solitary tumors and alteration in genes coding for energy metabolism with increasing grade. J Pathol. 2005;207:61-71.
23. Larramendy ML, Tarkkanen M, Valle J, et al. Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. Am J Pathol. 1997;150:685-691.
24. Morrison C, Radmacher M, Mohammed N, et al. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. J Clin Oncol. 2005;23:9369-9376.
25. Volarevic S, Stewart MJ, Ledermann B, et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science. 2000;288:2045-2047.
26. Sjogren H, Orndal C, Tingby O, Meis-Kindblom JM, Kindblom LG, Stenman G. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours, Int J Oncol. 2004;24:1385-1391.
27. Maelandsmo GM, Berner JM, Florenes VA, et al. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas-relationship to amplification and mRNA levels of CDK4 and CCND1. Br J Cancer. 1995;72:393-398.
28. Kim BT, Kitagawa H, Tamura J, et al. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4-N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/heparin biosynthesis. Proc Natl Acad Sci USA. 2001;98:7176-7181.
29. Bovee JVMG, Van den Broek LJCM, Cleton-Jansen AM, Hogendoorn PCW. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Invest. 2000;80:1925-1933.
30. Rozeman LB, Hameetman L, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW, Bovee JVMG. Absence of 1HH and retention of PTHrP signalling in enchondromas and central chondrosarcomas. J Pathol. 2005;205:476-482.
31. Kriajevska M, Fischer-Larsen M, Moertz E, et al. Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem. 2002;277:5229-5235.
32. Cheng J, Wang D, Wang Z, Yeh ET. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol. 2004;24:6021-6028.